CagriSema Dosing# CagriSema is a fixed-ratio combination in a single pen injector: Once-weekly subcutaneous injection containing both cagrilintide and semaglutide REDEFINE 1: Dose escalation to the maintenance combination dose over several weeks Dosing ratio: Fixed ratio optimized during the phase 2 program Dosing Comparison Table# Side Effects Comparison# Amycretin Side Effects# In the phase 1b/2a trial published in The Lancet, once-weekly subcutaneous amycretin up to 60 mg had a safety and tolerability profile consistent with GLP-1 and amylin agonists
Williams HC, Dellavalle RP, Garner S
It boosts the activity of genes that help with: Fixing DNA Fighting damage with antioxidants Rebuilding tissue proteins Growth Factor Stimulation : Studies find that GHK-Cu helps produce transforming growth factor-, vascular endothelial growth factor, and nerve growth factor, all of which are key to repairing tissues
Abbreviations AUC: Area under the curve AUROC: Area under the receiver operating characteristics BBJ: BioBank Japan BMI: Body mass index CfDNA: Cell-free DNA DT: Decision tree FPG: Fasting plasma glucose GDM: Gestational diabetes mellitus GWAS: Genome-wide association studies HbA1c: Glycated hemoglobin LD: Linkage disequilibrium Lm: Linear model LR: Logistic regression MAF: Minor allele frequency nB: Nave Bayes NIPT: Non-invasive prenatal testing OGTT: Oral glucose tolerance test PPV: Positive predictive value PRS: Polygenic risk score pTSS: Primary transcription start site RefSeq : Reference Sequence RF: Random forest SNVs: Single nucleotide variants SVM: Support vector machines T2DM: Type 2 diabetes mellitus TSS: Transcription start sites References Sweeting A, Hannah W, Backman H, Catalano P, Feghali M, Herman WH, et al
